Home » Medivir Signs Agreement With Daewoong to Distribute Xerclear in China and Hong Kong
Medivir Signs Agreement With Daewoong to Distribute Xerclear in China and Hong Kong
Medivir AB, a research-based specialty pharmaceutical company focused on infectious diseases, Thursday announced that it has signed an agreement with Daewoong Pharmaceutical Co. Ltd. to exclusively distribute Medivir’s unique cold sore treatment Xerclear in China and Hong Kong.
MarketWatch
MarketWatch
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May